N Anthony Coles - Net Worth and Insider Trading

N Anthony Coles Net Worth

The estimated net worth of N Anthony Coles is at least $2 Million dollars as of 2024-04-23. N Anthony Coles is the Director of Regeneron Pharmaceuticals Inc and owns about 1,093 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $995,679. N Anthony Coles is the Director of Cerevel Therapeutics Holdings Inc and owns about 15,638 shares of Cerevel Therapeutics Holdings Inc (CERE) stock worth over $655,467. N Anthony Coles is also the Director of McKesson Corp and owns about 0 shares of McKesson Corp (MCK) stock worth over $0. Details can be seen in N Anthony Coles's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that N Anthony Coles has not made any transactions after 2024-04-01 and currently still holds the listed stock(s).

Transaction Summary of N Anthony Coles

To

N Anthony Coles Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, N Anthony Coles owns 10 companies in total, including McKesson Corp () , Regeneron Pharmaceuticals Inc () , and CRISPR Therapeutics AG () among others .

Click here to see the complete history of N Anthony Coles’s form 4 insider trades.

Insider Ownership Summary of N Anthony Coles

Ticker Comapny Transaction Date Type of Owner
McKesson Corp 2020-08-17 director
Regeneron Pharmaceuticals Inc 2022-12-28 director
CRISPR Therapeutics AG 2016-10-18 director
Campus Crest Communities Inc 2013-04-22 director
Laboratory Corp of America Holdings 2011-01-03 director
Vertex Pharmaceuticals Inc 2003-12-11 SVP & Comm. Ops.
Yumanity Therapeutics Inc 2020-12-22 director & Executive Chair
Campus Crest Communities Inc 2013-04-22 director
Cerevel Therapeutics Holdings Inc 2024-04-01 director & See Remarks
Kineta Inc 2020-12-22 director & Executive Chair

N Anthony Coles Latest Holdings Summary

N Anthony Coles currently owns a total of 3 stocks. Among these stocks, N Anthony Coles owns 1,093 shares of Regeneron Pharmaceuticals Inc (REGN) as of December 28, 2022, with a value of $995,679 and a weighting of 60.3%. N Anthony Coles owns 15,638 shares of Cerevel Therapeutics Holdings Inc (CERE) as of April 1, 2024, with a value of $655,467 and a weighting of 39.7%. N Anthony Coles also owns 0 shares of McKesson Corp (MCK) as of August 17, 2020, with a value of $0 and a weighting of 0%.

Latest Holdings of N Anthony Coles

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
REGN Regeneron Pharmaceuticals Inc 2022-12-28 1,093 910.96 995,679
CERE Cerevel Therapeutics Holdings Inc 2024-04-01 15,638 41.92 655,467
MCK McKesson Corp 2020-08-17 0 530.91 0

Holding Weightings of N Anthony Coles


N Anthony Coles Form 4 Trading Tracker

According to the SEC Form 4 filings, N Anthony Coles has made a total of 5 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 5,758 shares on December 28, 2022, which brought N Anthony Coles around $4 Million.

According to the SEC Form 4 filings, N Anthony Coles has made a total of 17 transactions in Cerevel Therapeutics Holdings Inc (CERE) over the past 5 years, including 0 buys and 17 sells. The most-recent trade in Cerevel Therapeutics Holdings Inc is the sale of 50,000 shares on April 1, 2024, which brought N Anthony Coles around $2 Million.

According to the SEC Form 4 filings, N Anthony Coles has made a total of 1 transactions in McKesson Corp (MCK) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in McKesson Corp is the sale of 2,453 shares on August 17, 2020, which brought N Anthony Coles around $384,557.

Insider Trading History of N Anthony Coles

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

N Anthony Coles Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

N Anthony Coles Ownership Network

Ownership Network List of N Anthony Coles

No Data

Ownership Network Relation of N Anthony Coles


N Anthony Coles Owned Company Details

What does McKesson Corp do?

Who are the key executives at McKesson Corp?

N Anthony Coles is the director of McKesson Corp. Other key executives at McKesson Corp include Chief Executive Officer Brian S. Tyler , SVP & Controller & CAO Rutledge Napoleon B Jr , and EVP & Chief HR Officer Leann B Smith .

McKesson Corp () Insider Trades Summary

Over the past 18 months, N Anthony Coles made no insider transaction in McKesson Corp (). Other recent insider transactions involving McKesson Corp () include a net sale of 168,590 shares made by Brian S. Tyler , a net sale of 19,377 shares made by Lori A. Schechter , and a net sale of 7,741 shares made by Nancy Flores .

In summary, during the past 3 months, insiders sold 3,849 shares of McKesson Corp () in total and bought 0 shares, with a net sale of 3,849 shares. During the past 18 months, 232,576 shares of McKesson Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 232,576 shares.

McKesson Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

McKesson Corp Insider Transactions

No Available Data

N Anthony Coles Mailing Address

Above is the net worth, insider trading, and ownership report for N Anthony Coles. You might contact N Anthony Coles via mailing address: Morris Corp. Center I; Bldg. B; 4th Flr., 300 Interpace Parkway, Parsippany Nj 07054.

Discussions on N Anthony Coles

No discussions yet.